CAPTRUST Financial Advisors
XLRN

CAPTRUST Financial Advisors’s Acceleron Pharma XLRN Stock Holding History

CAPTRUST Financial Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-58
Closed -$10K – 5070
2021
Q3 		$10K Buy
58
+5
+9% +$654 ﹤0.01% 3636
2021
Q2 		$7K Buy
53
+2
+4% +$252 ﹤0.01% 3739
2021
Q1 		$7K Buy
+51
New +$6.59K ﹤0.01% 3622
2018
Q3 		– Sell
-3
Closed – – 1744
2018
Q2 		$0 Buy
+3
New +$109 ﹤0.01% 1638

CAPTRUST Financial Advisors's XLRN Position: Q4 2021 in Review

CAPTRUST Financial Advisors sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 58 shares — an estimated $10K sold.

CAPTRUST Financial Advisors first reported a position in XLRN in Q2 2018 and held it in 4 quarters. The position peaked at $10K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • CAPTRUST Financial Advisors reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 58 Acceleron Pharma shares in Q4 2021, an estimated $10K.
  • CAPTRUST Financial Advisors first reported a position in Acceleron Pharma in Q2 2018 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's Acceleron Pharma position peaked at $10K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.